Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery

References

• Aisha AFA, Ismail Z, Abu-Salah KM, Majid AMSA. Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles. J Pharm Sci, 2012;101(2):815–25
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Nozawa Y. Anti-cancer effects of xanthones from pericarps of mangosteen. Int J Mol Sci, 2008;9:355–70
   PubMed Web of Science ®Google Scholar
• Ali AAE, Taher M, Helaluddin ABM, Mohamed F. Development and validation of analytical method by RP-HPLC for quantification of alpha-mangostin encapsulated in PLGA microspheres. J Anal Bioanal Tech, 2012;3:7. doi: http://dx.doi.org/10.4172/2155-9872.1000155
   Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Indu Pharm, 1999;25:471–6
   PubMed Web of Science ®Google Scholar
• Bouissou C, Potter U, Altroff H, Mardon H, Van Der Walle C. Controlled release of the fibronectin central cell binding domain from polymeric microspheres. J Control Release, 2004;95:557–66
   PubMed Web of Science ®Google Scholar
• Bouissou C, Rouse J, Price R, Van der walle C. The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release. Pharm Res, 2006;23:1295–305
   PubMed Web of Science ®Google Scholar
• Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol, 2008;46:688–93
   PubMed Web of Science ®Google Scholar
• Cui J, Hu W, Cai Z, Liu Y, Li S, Tao W, Xiang H. New medicinal properties of mangostins: Analgesic activity and pharmacological characterization of active ingredients from the fruit hull of Garcinia mangostana L. Pharmacol Biochem Behav, 2010;95:166–72
   PubMed Web of Science ®Google Scholar
• Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Mirzadeh H, Fakhari A, Nokhodchi A. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. J Microencapsul, 2009;26:1–8
   PubMed Web of Science ®Google Scholar
• Fiegel J, Fu J, Hanes J. Poly (ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. J Control Release, 2004;96:411–23
   PubMed Web of Science ®Google Scholar
• Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res, 1998;243:359–66
   PubMed Web of Science ®Google Scholar
• Gohel M, Amin A. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release, 1998;51:115–22
   PubMed Web of Science ®Google Scholar
• Huo D, Deng S, Li L, Ji J. Studies on the poly (lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm, 2005;289:63–7
   PubMed Web of Science ®Google Scholar
• Ibrahim HM, Ahmed TA, Lila AEA, Samy AM, Kaseem AA, Nutan MTH. Mucoadhesive controlled release microcapsules of indomethacin: Optimization and stability study. J Microencapsul, 2010;27:377–86
   PubMed Web of Science ®Google Scholar
• Iikubo K, Ishikawa Y, Ando N, Umezawa K, Nishiyama S. The first direct synthesis of [alpha]-mangostin, a potent inhibitor of the acidic sphingomyelinase. Tetrahedron Lett, 2002;43:291–3
   Web of Science ®Google Scholar
• Harun Ismail AF, Doolanea AM, Awang M, Mohamed F. High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection. Int J Pharm Pharm Sci, 2012;4(Suppl. 4):685–91
   Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin, 2011;61(2):69–90
   PubMed Web of Science ®Google Scholar
• Ji X, Gao Y, Chen L, Zhang Z, Deng Y, Li Y. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance. Int J Pharm, 2012;422:390–97
   PubMed Web of Science ®Google Scholar
• Jung, HA, Su BN, Keller WJ, Mehta RG, Kinghorn AD. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem, 2006;54:2077–82
   PubMed Web of Science ®Google Scholar
• Kaomongkolgit R, Jamdee K, Chaisomboon N. Antifungal activity of alpha-mangostin against Candida albicans. J Oral Sci, 2009;51:401–6
   PubMedGoogle Scholar
• Liu DZ, Chen, WP, Lee CP, Wu SL, Wang YC, Chung TW. Effects of alginate coated on PLGA microspheres for delivery tetracycline hydrochloride to periodontal pockets. J Microencapsul, 2004;21:643–52
   PubMed Web of Science ®Google Scholar
• Mahabusarakam W, Proudfoot J, Taylor W, Croft K. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic Res, 2000;33:643–59
   PubMed Web of Science ®Google Scholar
• Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm, 2007;334(1–2):137–48
   PubMed Web of Science ®Google Scholar
• Mohamed F, van der Walle CF. PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA. Int J Pharm, 2006;311(1–2):97–107
   PubMed Web of Science ®Google Scholar
• Mohamed F, van der Walle CF. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci, 2008;97:71–87
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 1983;65:55–63
   PubMed Web of Science ®Google Scholar
• Murphy TD. 2007. Response surface methodology for validation of oral dosage forms. In: Torbeck LD, ed. Pharmaceutical and medical device validation by experimental design. New York: Informa Healthcare
   Google Scholar
• Nasr M, Awad GAS, Mansour S, Al shamy A, Mortada ND. A reliable predictive factorial model for entrapment optimization of a sodium bisphosphonate into biodegradable microspheres. J Pharm Sci, 2011;100:612–21
   PubMed Web of Science ®Google Scholar
• Pedraza-Chaverri J, Reyes-Fermin LM, Nolasco-Amaya EG, Orozco-Ibarra M, Medina-Campos ON, Gonzalez-Cuahutencos O, Rivero-Cruz I, Mata R. ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. Exp Toxicol Pathol, 2009;61:491–501
   PubMed Web of Science ®Google Scholar
• Pothitirat W, Gritsanapan W. HPLC quantitative analysis method for the determination of α-mangostin in mangosteen fruit rind extract. Thai J Agri Sci, 2009;42:7–12
   Google Scholar
• Ricci M, Giovagnoli S, Blasi P, Schoubben A, Perioli L, Rossi C. Development of liposomal capreomycin sulfate formulations: Effects of formulation variables on peptide encapsulation. Int J Pharm, 2006;311:172–81
   PubMed Web of Science ®Google Scholar
• Rouse JJ, Mohamed F, van der Walle CF. Physical ageing and thermal analysis of PLGA microspheres encapsulating protein or DNA. Int J Pharm, 2007;339(1–2):112–20
   Google Scholar
• Sakagami Y, Iinuma M, Piyasena KG, Dharmaratne HR. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine, 2005;12:203–8
   PubMed Web of Science ®Google Scholar
• Scholes P, Coombes A, Illum L, Daviz S, Vert M, Davies M. The preparation of sub-200 nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Release, 1993;25:145–53
   Web of Science ®Google Scholar
• Shih YW, Chien ST, Chen PS, Lee JH, Wu SH, Yin LT. Alpha mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via avb3 integrin/FAK/ERK and NF-jB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem Biophys, 2010;58:31–44
   PubMed Web of Science ®Google Scholar
• Suksamrarn S, Komutiban O, Ratananukul P, Chimnoi N, Lartpornmatulee N, Suksamrarn A. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem Pharmaceut Bull, 2006;54:301–5
   PubMed Web of Science ®Google Scholar
• Taher M, Susanti D, Rezali MF, Zohri FSA, Ichwan SJA, Alkhamaiseh SI, Ahmad F. Apoptosis, antimicrobial and antioxidant activities of phytochemicals from Garcinia malaccensis Hk.f. Asian Pac J Trop Med, 2012;5:136–41
   PubMed Web of Science ®Google Scholar
• Tangpong J, Miriyala S, Noel T, Sinthupibulyakit C, Jungsuwadee P, St. Clair DK. Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia Mangostana. Neuroscience, 2011;175:292–9
   PubMed Web of Science ®Google Scholar
• Teixeira M, Alonso MJ, Pinto MMM, Barbosa CM. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm, 2005;59:491–500
   PubMed Web of Science ®Google Scholar
• Wang Y, Xia Z, Xu JR, Wang YX, Hou LN, Qiu Y, Chen HZ. α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation. Neuropharmacology, 2012;62(2):871–81
   PubMed Web of Science ®Google Scholar
• Williams P, Ongsakul M, Proudfoot J, Croft K, Beilin L. Mangostin inhibits the oxidative modification of human low density lipoprotein. Free Radic Res, 1995;23:175–84
   PubMed Web of Science ®Google Scholar
• Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm, 2008;364:298–327
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev, 2007;59:491–504
   PubMed Web of Science ®Google Scholar
• Xu Q, Czernuszka JT. Controlled release of amoxicillin from hydroxyapatite-coated poly (lactic-co-glycolic acid) microspheres. J Control Release, 2008;127:146–53
   PubMed Web of Science ®Google Scholar
• Yoo HS, Lee KH, Oh JE, Park TG. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Rel, 2000;68:419–31
   PubMed Web of Science ®Google Scholar
• Zeng XM, MacRitchie HB, Marriott C, Martin GP. Huimidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Int J Pharm, 2007;333(1–2):45–55
   PubMedGoogle Scholar
• Zu Y, Zhang Y, Zhao X, Zhang Q, Liu Y, Jiang R. Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM). Int J Nanomedicine, 2009;4:321–33
   PubMed Web of Science ®Google Scholar